Evidence map›Paper›PMID 28825379›Full record

ArticleStem cells and development2017

Oncostatin M and TNF-α Induce Alpha-1 Antitrypsin Production in Undifferentiated Adipose Stromal Cells.

Kevin Ni, Muhammad Umair Mukhtar Mian, Catherine Meador, Amar Gill, Daria Barwinska, Danting Cao, Matthew J Justice, Di Jiang, Niccolette Schaefer, Kelly S Schweitzer and 3 more

Abstract read
In one paragraph

Article in Stem cells and development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kevin Ni1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Muhammad Umair Mukhtar Mian2 Department of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Catherine Meador2 Department of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Amar Gill1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Daria Barwinska2 Department of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Danting Cao1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Matthew J Justice1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Di Jiang1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Niccolette Schaefer1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Kelly S Schweitzer1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Hong Wei Chu1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Keith L March2 Department of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Irina Petrache1 Department of Medicine, National Jewish Health, University of Colorado School of Medicine , Denver, Colorado.
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Indiana Medical Scientist/Engineer Training ProgramT32GM077229 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN, HERBERT, BRITTNEY-SHEA · 2008 to 2022
$6.0M
IU Training Program in Molecular Physiology and Clinical Mechanisms of Lung DiseaseT32HL091816 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI Erick Forno, Roberto F. Machado · 2009 to 2026
$4.3M
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in EmphysemaR01HL105772 · NHLBI · NATIONAL JEWISH HEALTH · PI MARCH, KEITH LEONARD, PETRACHE, IRINA · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL105772NHLBI NIH HHS T32 HL091816NIGMS NIH HHS T32 GM077229
6 · The paper itself

Abstract

Alpha-1 antitrypsin (A1AT), a circulating acute-phase reactant antiprotease, is produced and secreted by cells of endodermal epithelial origin, primarily hepatocytes, and by immune cells. Deficiency of A1AT is associated with increased risk of excessive lung inflammation and injury, especially following chronic cigarette smoke (CS) exposure. Exogenous administration of mesenchymal progenitor cells, including adipose tissue-derived stromal/stem cells (ASC), alleviates CS-induced lung injury through paracrine effectors such as growth factors. It is unknown, however, if mesodermal ASC can secrete functional A1AT and if CS exposure affects their A1AT production. Human ASC collected via liposuction from nonsmoking or smoking donors were stimulated by inflammatory cytokines tumor necrosis alpha (TNFα), oncostatin M (OSM), and/or dexamethasone (DEX) or were exposed to sublethal concentrations of ambient air control or CS extract (0.5%-2%). We detected minimal expression and secretion of A1AT by cultured ASC during unstimulated conditions, which significantly increased following stimulation with TNFα or OSM. Furthermore, TNFα and OSM synergistically enhanced A1AT expression and secretion, which were further increased by DEX. The A1AT transcript variant produced by stimulated ASC resembled that produced by bronchial epithelial cells rather than the variant produced by monocytes/macrophages. While the cigarette smoking status of the ASC donor had no measurable effect on the ability of ASC to induce A1AT expression, active exposure to CS extract markedly reduced A1AT expression and secretion by cultured ASC, as well as human tracheobronchial epithelial cells. ASC-secreted A1AT covalently complexed with neutrophil elastase in control ASC, but not in cells transfected with A1AT siRNA. Undifferentiated ASC may require priming to secrete functional A1AT, a potent antiprotease that may be relevant to stem cell therapeutic effects.

Indexed as

Cell DifferentiationAdipose Tissuealpha 1-AntitrypsinBronchiCell LineCigarette SmokingEpithelial CellsHumansLeukocyte ElastaseMacrophagesOncostatin MRNA, MessengerStromal CellsTumor Necrosis Factor-alphaalpha 1-AntitrypsinLeukocyte ElastaseOncostatin MRNA, MessengerTumor Necrosis Factor-alphaalpha-1-proteinase inhibitorcigarette smokehuman adipose progenitor cell

Identifiers

PMID28825379
PMCPMC5651966
OpenAlexW2749694737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.